Zobrazeno 1 - 10
of 40
pro vyhledávání: '"Iftakhar Alam"'
Publikováno v:
PLoS ONE, Vol 19, Iss 4, p e0302059 (2024)
This study aimed to explore the prevalence and determinants of discrimination against or harassment among Bangladeshi women. The nationally representative cross-sectional data of the Multiple Indicator Cluster Survey 2019 were employed in the study.
Externí odkaz:
https://doaj.org/article/b76da949040f485bab61f6de177481b4
Publikováno v:
PLoS ONE, Vol 19, Iss 3, p e0300403 (2024)
Functional difficulty in children is a crucial public health problem still undervalued in developing countries. This study explored the socio-demographic factors and anthropometry associated with children's functional difficulty in Bangladesh. Data f
Externí odkaz:
https://doaj.org/article/202a874f19c943e3827f1c912ccc054a
Autor:
M. Iftakhar Alam, Nigar Sultana
Publikováno v:
Austrian Journal of Statistics, Vol 50, Iss 5 (2021)
This paper describes a method for the construction of pharmacokinetic sampling windows so that they are around the $D$-optimum time points. Here we consider the situation where a pharmacokinetic (PK) study is accompanied by a dose-finding study in ph
Externí odkaz:
https://doaj.org/article/c352aa1b00f94532acd243a3e14a8c5a
Autor:
Rahman, Rezoanoor1 (AUTHOR), Iftakhar Alam, M.1 (AUTHOR) iftakhar@isrt.ac.bd
Publikováno v:
Journal of Applied Statistics. Aug2022, Vol. 49 Issue 10, p2447-2466. 20p. 3 Charts, 1 Graph.
Autor:
M. Iftakhar Alam, Jafrin Sultana
Publikováno v:
Austrian Journal of Statistics, Vol 48, Iss 5 (2019)
One of the most challenging tasks in clinical trials is finding the maximum tolerated dose (MTD) to be tested in the next phase. An assurance for the safety of the patients and recommendation of a suitable dose for phase II are the main objectives of
Externí odkaz:
https://doaj.org/article/004a4d8ac0424df28c78acd605cc5aec
Publikováno v:
Sequential Analysis. 41:367-386
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::e1a9631f2190beca6b366d69b2895c07
https://doi.org/10.1080/07474946.2022.2105361
https://doi.org/10.1080/07474946.2022.2105361
Autor:
Hasan Mahmud Sujan, M Iftakhar Alam
Publikováno v:
Journal of Statistical Research. 55:313-334
Determining the maximum tolerated dose (MTD) is the main challenge of phase I clinical trials. There are many methods in the literature to determine the MTD. The D-optimal design can also be used to find the MTD. The D-optimal design depends on the F
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::3198b79487b136ab67830918a1637884
https://doi.org/10.3329/jsr.v55i2.58808
https://doi.org/10.3329/jsr.v55i2.58808
Publikováno v:
Biometrical Letters. 58:133-147
Summary Sample size calculation is an integral part of any clinical trial design, and determining the optimal sample size for a study ensures adequate power to detect statistical significance. It is a critical step in designing a planned research pro
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::c3aefba88fde975aef06afbe44a485f3
https://doi.org/10.2478/bile-2021-0010
https://doi.org/10.2478/bile-2021-0010
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.